Israel and US-based medical device company V-Wave has closed a $28m series B round featuring Johnson & Johnson Innovation, the investment unit of pharmaceutical firm Johnson & Johnson, and medical equipment manufacturer Edwards Lifesciences.
TriVentures, Pura Vida Investments, BRM Capital, BioStar Ventures and Pontifax also participated in the round.
Founded in 2010, V-Wave is working on a minimally invasive device to treat patients suffering from chronic symptomatic heart failure. The company hopes the device, dubbed V-Wave Unidirectional Shunt System, will…